GABA Agonists: all 23 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- Placebo-Controlled, Single-Dose Challenge Study of Gaboxadol in Adult Males With Fragile X Syndrome (FXS)CompletedNCT06334419Phase 2Results postedHow we know
- A Study of OV101 in Individuals With Angelman Syndrome (AS)CompletedNCT04106557Phase 3Results postedHow we know
- An Open-Label Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of OV101 in Individuals With Angelman SyndromeTerminatedNCT03882918Phase 3Results postedHow we know
- A Study of OV101 in Individuals With Fragile X SyndromeCompletedNCT03697161Phase 2Results postedHow we know
- A Study in Adults and Adolescents With Angelman Syndrome (STARS)CompletedNCT02996305Phase 2Results postedHow we know
- Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive DisorderCompletedNCT00807248Phase 2Results postedHow we know
- The Effects of Cannabidiol and Homotaurine in Patients With Mild Cognitive ImpairmentStatus unknownNCT05022186Phase 4How we know
- Investigation of Sulindac (HLX-0201) and Gaboxadol (HLX-0206) in Male Fragile X Syndrome Patients Aged 13-40WithdrawnNCT04823052Phase 2How we know
- Single Dose Pharmacokinetic (PK) StudyCompletedNCT03109756Phase 1How we know
- How Your Patients' Non-REM Sleep Changes On Sedatives in the Intensive Care UnitsTerminatedNCT00826553Phase 1How we know
- Efficacy and Safety Study of Adipiplon, Placebo and an Active Control in Primary InsomniacsTerminatedNCT00683436Phase 2How we know
- Open-Label Extension of the Phase III Study With Tramiprosate (3APS) in Patients With Mild to Moderate Alzheimer's DiseaseStatus unknownNCT00314912Phase 3How we know
- European Study of 3APS in Mild to Moderate Alzheimer's Disease PatientsStatus unknownNCT00217763Phase 3How we know
- A Study of Gaboxadol in Primary InsomniaCompletedNCT00209963Phase 3How we know
- A Prospective Open-Label Extension Study of Gaboxadol in Primary InsomniaCompletedNCT00209950Phase 3How we know
- A Prospective Active-Reference Study of Gaboxadol in Primary InsomniaCompletedNCT00209937Phase 3How we know
- A Study of Gaboxadol in Primary InsomniaCompletedNCT00209924Phase 3How we know
- A Study of Gaboxadol in Primary InsomniaCompletedNCT00209846Phase 3How we know
- An Investigational Study of MK0928 in Adult Outpatients With Insomnia (0928-014)(COMPLETED)CompletedNCT00103818Phase 3How we know
- Study of MK0928 in Healthy Adult Volunteers in a Model of Insomnia (0928-006)(COMPLETED)CompletedNCT00102167Phase 3How we know
- Safety of MK0928 on Insomnia in the Elderly (0928-005)(COMPLETED)CompletedNCT00095043Phase 3How we know
- Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED)CompletedNCT00094627Phase 3How we know
- Evaluation of 3APS in Patients With Mild to Moderate Alzheimer's DiseaseStatus unknownNCT00088673Phase 3How we know